课题基金 / 基金详情

项目摘要

项目成果

Nan-ping Peter Weng的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lysine specific methyltransferase 2D (Kmt2d) catalyzes the mono-methylation of histone 3 lysine 4 (H3K4me1) and plays a critical role in regulatory T cell generation via modulating Foxp3 gene expression. Here we report a role of Kmt2d in nave CD8+ T cell generation and survival. In the absence of Kmt2d, the number of CD8+ T cells, particularly nave CD8+ T cells (CD62Lhi/CD44lo), in spleen was greatly decreased and in vitro activation-related death significantly increased from Kmt2dfl/flCD4cre+ (KO) compared to Kmt2dfl/flCD4cre- (WT) mice. Furthermore, analyses by ChIPseq, RNAseq, and scRNAseq showed reduced H3K4me1 levels in enhancers and reduced expression of apoptosis-related genes in activated nave CD8+ T cells in the absence of Kmt2d. Finally, we confirmed the activation-induced death of antigen-specific nave CD8+ T cells in vivo in Kmt2d KO mice upon challenge with Listeria monocytogenes infection. These findings reveal that Kmt2d regulates activation-induced nave CD8+ T cell survival via modulating H3K4me1 levels in enhancer regions of apoptosis and immune function-related genes. The ability of T cells to undergo robust cell division in response to antigenic stimulation is essential for competent T cell function. However, this ability is reduced with aging, contributing to an increased susceptibility to infectious diseases, cancers, and other diseases among older adults. To better understand T cell aging, improved measurements of age-related cellular changes in T cells are necessary. The recent development of a machine-learning assisted transcriptome-based quantification of individual CD8+ T cell age represents a significant step forward in this regard. It reveals both prominent and subtle changes in gene expression and points to potential functional alterations of CD8+ T cells with aging. By capturing differences in the status of cell differentiation and history of cell divisions, this algorithm assigns different ages to CD8+ T cells, which enables researchers to better comprehend the impact of age on the functions of individual CD8+ T cells. We argue that single cell transcriptome-based age prediction in the immune system may have promising future applications.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2013.00121
发表时间: 2013
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Chen G, Lustig A, Weng NP]
通讯作者: Weng NP
DOI: 10.1016/j.isci.2023.106335
发表时间: 2023-04-21
期刊: iScience
影响因子: 5.8
作者: [Amano T, Yu H, Amano M, Leyder E, Badiola M, Ray P, Kim J, Ko AC, Achour A, Weng NP, Kochba E, Levin Y, Ko MSH]
通讯作者: Ko MSH
Research on immunity and ageing comes of age.
关于免疫和衰老的研究已经成熟。
DOI: 10.1186/s12979-019-0148-9
发表时间: 2019
期刊: Immunity & ageing : I & A
影响因子: --
作者: [Weng,Nan-Ping, Pawelec,Graham]
通讯作者: Pawelec,Graham
MOLECULAR ANALYSIS OF HUMAN NAIVE AND MEMORY T CELLS
  • 批准号:
    6288747
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Nan-ping Peter Weng
  • 依托单位:
Mechanisms Of Age-related Changes in Transcriptional Regulation in lympphocytes
  • 批准号:
    9551862
  • 项目类别:
  • 资助金额:
    $23.8万
  • 财政年份:
    --
  • 负责人:
    Nan-ping Peter Weng
  • 依托单位:
Regulation and function of telomerase in T cells
  • 批准号:
    9348182
  • 项目类别:
  • 资助金额:
    $26.19万
  • 财政年份:
    --
  • 负责人:
    Nan-ping Peter Weng
  • 依托单位:
Role of Telomere and telomerase In Human Lymphocyte Function and Aging
  • 批准号:
    10007356
  • 项目类别:
  • 资助金额:
    $44.62万
  • 财政年份:
    --
  • 负责人:
    Nan-ping Peter Weng
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: